[go: up one dir, main page]

EP1272224A4 - Gene expression profiles in esophageal tissue - Google Patents

Gene expression profiles in esophageal tissue

Info

Publication number
EP1272224A4
EP1272224A4 EP01924375A EP01924375A EP1272224A4 EP 1272224 A4 EP1272224 A4 EP 1272224A4 EP 01924375 A EP01924375 A EP 01924375A EP 01924375 A EP01924375 A EP 01924375A EP 1272224 A4 EP1272224 A4 EP 1272224A4
Authority
EP
European Patent Office
Prior art keywords
gene expression
expression profiles
esophageal tissue
esophageal
tissue
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP01924375A
Other languages
German (de)
French (fr)
Other versions
EP1272224A1 (en
Inventor
Amanda Williams
Joseph F Boland
Reginald V Lord
Christopher Alvares
Jon C Wetzel
Uwe Scherf
Joseph G Vockley
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ore Pharmaceuticals Inc
Original Assignee
Ore Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ore Pharmaceuticals Inc filed Critical Ore Pharmaceuticals Inc
Publication of EP1272224A1 publication Critical patent/EP1272224A1/en
Publication of EP1272224A4 publication Critical patent/EP1272224A4/en
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B25/00—ICT specially adapted for hybridisation; ICT specially adapted for gene or protein expression
    • G16B25/10—Gene or protein expression profiling; Expression-ratio estimation or normalisation
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/136—Screening for pharmacological compounds
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B25/00—ICT specially adapted for hybridisation; ICT specially adapted for gene or protein expression
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B40/00—ICT specially adapted for biostatistics; ICT specially adapted for bioinformatics-related machine learning or data mining, e.g. knowledge discovery or pattern finding

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Physics & Mathematics (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Biotechnology (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • Theoretical Computer Science (AREA)
  • Zoology (AREA)
  • Immunology (AREA)
  • Medical Informatics (AREA)
  • Pathology (AREA)
  • Evolutionary Biology (AREA)
  • Analytical Chemistry (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Wood Science & Technology (AREA)
  • Oncology (AREA)
  • Microbiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
EP01924375A 2000-03-31 2001-03-28 Gene expression profiles in esophageal tissue Withdrawn EP1272224A4 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US19344600P 2000-03-31 2000-03-31
US193446P 2000-03-31
US23773300P 2000-10-05 2000-10-05
US237733P 2000-10-05
PCT/US2001/009847 WO2001074405A1 (en) 2000-03-31 2001-03-28 Gene expression profiles in esophageal tissue

Publications (2)

Publication Number Publication Date
EP1272224A1 EP1272224A1 (en) 2003-01-08
EP1272224A4 true EP1272224A4 (en) 2004-09-29

Family

ID=26888993

Family Applications (1)

Application Number Title Priority Date Filing Date
EP01924375A Withdrawn EP1272224A4 (en) 2000-03-31 2001-03-28 Gene expression profiles in esophageal tissue

Country Status (4)

Country Link
EP (1) EP1272224A4 (en)
AU (1) AU2001251034A1 (en)
CA (1) CA2405431A1 (en)
WO (1) WO2001074405A1 (en)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE412053T1 (en) * 2000-07-19 2008-11-15 Takara Bio Inc METHOD FOR DETECTING CANCER
WO2004020668A2 (en) * 2002-08-30 2004-03-11 Oncotherapy Science, Inc. Method for treating synovial sarcoma
US7803370B2 (en) 2002-08-30 2010-09-28 Oncotherapy Science, Inc. Method for treating synovial sarcoma
AU2003295511A1 (en) * 2002-11-13 2004-06-03 Genentech, Inc. Methods and compositions for diagnosing dysplasia
WO2005076005A2 (en) * 2004-01-30 2005-08-18 Medizinische Universität Wien A method for classifying a tumor cell sample based upon differential expression of at least two genes
US20050186577A1 (en) 2004-02-20 2005-08-25 Yixin Wang Breast cancer prognostics
CA2596845C (en) * 2005-02-10 2016-11-08 Government Of The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Method of diagnosing and treating cancer using b-catenin splice variants
US7932032B2 (en) 2005-05-02 2011-04-26 Toray Industries, Inc. Method for diagnosing esophageal cancer
US8053183B2 (en) 2005-07-27 2011-11-08 Oncotherapy Science, Inc. Method of diagnosing esophageal cancer
GB0526498D0 (en) * 2005-12-28 2006-02-08 Randox Lab Ltd Method
EP2044123B1 (en) 2006-06-21 2013-03-13 Oncotherapy Science, Inc. Tumor-targeting monoclonal antibodies to fzd10 and uses thereof
US8450057B2 (en) * 2006-08-14 2013-05-28 The Brigham And Women's Hospital, Inc. Diagnostic tests using gene expression ratios
US8945849B2 (en) 2008-05-21 2015-02-03 Toray Industries, Inc. Method for diagnosing esophageal cancer
GB201005048D0 (en) 2010-03-24 2010-05-12 Medical Res Council Prognosis of oesophageal and gastro-oesophageal junctional cancer
US10018631B2 (en) 2011-03-17 2018-07-10 Cernostics, Inc. Systems and compositions for diagnosing Barrett's esophagus and methods of using the same
GB201208756D0 (en) * 2012-05-17 2012-07-04 Medical Res Council Methods
US10962544B2 (en) 2015-11-25 2021-03-30 Cernostics, Inc. Methods of predicting progression of Barrett's esophagus
TWI762516B (en) 2016-10-06 2022-05-01 日商腫瘤療法 科學股份有限公司 Monoclonal antibodies against FZD10 and their uses
CN109342729B (en) * 2018-10-30 2021-06-25 深圳格道糖生物技术有限公司 Use of specific lectin combinations for the identification of esophageal cancer based on sialylated forms

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001094629A2 (en) * 2000-06-05 2001-12-13 Avalon Pharmaceuticals Cancer gene determination and therapeutic screening using signature gene sets
WO2002064171A1 (en) * 2001-02-12 2002-08-22 Thomas Jefferson University Adenoviral transduction of fragile histidine triad (fhit) into cancer cells

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2219136A1 (en) * 1995-04-24 1996-10-31 Chromaxome Corp. Methods for generating and screening novel metabolic pathways
EP1012240B1 (en) * 1997-01-31 2008-03-19 Edward P. Cohen Cancer immunotherapy with semi-allogeneic cells
US6188783B1 (en) * 1997-07-25 2001-02-13 Affymetrix, Inc. Method and system for providing a probe array chip design database

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001094629A2 (en) * 2000-06-05 2001-12-13 Avalon Pharmaceuticals Cancer gene determination and therapeutic screening using signature gene sets
WO2002064171A1 (en) * 2001-02-12 2002-08-22 Thomas Jefferson University Adenoviral transduction of fragile histidine triad (fhit) into cancer cells

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
DATABASE MEDLINE [online] US NATIONAL LIBRARY OF MEDICINE (NLM), BETHESDA, MD, US; October 1999 (1999-10-01), ZHOU J ET AL: "[Gene expression profiles in squamous esophageal cancer tissues and adjacent almost normal tissues]", XP002273969, Database accession no. NLM10514537 *
SEBASTIAN J L ET AL: "The use of large-scale cDNA analysis to profile differential gene expression in KYSE 410 human esophageal cancer cells after irradiation.", BULLETIN OF EXPERIMENTAL BIOLOGY AND MEDICINE. UNITED STATES SEP 2000, vol. 130, no. 9, September 2000 (2000-09-01), pages 882 - 885, XP009027930, ISSN: 0007-4888 *
See also references of WO0174405A1 *
ZHONGHUA YI XUE YI CHUAN XUE ZA ZHI = ZHONGHUA YIXUE YICHUANXUE ZAZHI = CHINESE JOURNAL OF MEDICAL GENETICS. CHINA OCT 1999, vol. 16, no. 5, October 1999 (1999-10-01), pages 303 - 306, ISSN: 1003-9406 *

Also Published As

Publication number Publication date
WO2001074405B1 (en) 2001-11-29
WO2001074405A1 (en) 2001-10-11
WO2001074405A9 (en) 2003-06-12
EP1272224A1 (en) 2003-01-08
CA2405431A1 (en) 2001-10-11
AU2001251034A1 (en) 2001-10-15

Similar Documents

Publication Publication Date Title
EP1272224A4 (en) Gene expression profiles in esophageal tissue
AU2002253878A1 (en) Gene expression profiles in breast tissue
IL135371A0 (en) Resectoscope
GB0011244D0 (en) Tissue regrafting
GB2390330B (en) Dough roller
EP1354950A4 (en) Nf-kb activating gene
AU147240S (en) Dough roller
GB0031852D0 (en) Roller skate
EP1291424A4 (en) Gasc1 gene
WO2001098454A8 (en) Human dna sequences
GB0003053D0 (en) Improvements in baking ovens
GB0305841D0 (en) Human telomerase rna elements
AU2002364077A8 (en) Gene expression profiles in stomach cancer
PL356710A1 (en) Roller
AU2002324701A1 (en) Gene expression profiles in glomerular diseases
GB0100739D0 (en) Resectoscopes
CA94543S (en) Bread roll
TW472616U (en) Walk-assist roller skates
AU2002211753A8 (en) Gene expression modulated in spontaneous inflammatory bowel disease
AU143726S (en) Tissue
AU144071S (en) Tissue
GB0028322D0 (en) Improvements in Bakery ovens
CA92319S (en) Embossed tissue
CA89807S (en) Embossed bath tissue
CA89806S (en) Embossed bath tissue

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20021028

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR

AX Request for extension of the european patent

Free format text: AL;LT;LV;MK;RO;SI

RIC1 Information provided on ipc code assigned before grant

Ipc: 7A 61K 31/7088 B

Ipc: 7C 12Q 1/68 B

Ipc: 7G 01N 33/574 B

Ipc: 7G 06F 19/00 A

A4 Supplementary search report drawn up and despatched

Effective date: 20040811

17Q First examination report despatched

Effective date: 20050628

17Q First examination report despatched

Effective date: 20050628

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20071002